Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Myriad Genetics: Profits In Predictive Medicine
Dec 01, 2008 10:10 AM
- Technical Picture - Inside Day
Nov 10, 2008 12:43 AM
- Obama-Care Focused on Preventive Medicine
Nov 05, 2008 07:20 PM
- Earnings Review Of Election Day Market Movers
Nov 04, 2008 11:35 AM
- Covered Call Writing - Screen of the Week
Oct 14, 2008 04:58 PM
- Best Perfomers Over Last Quarter
Oct 06, 2008 02:19 AM
- Biotechs: Buy The Big Dip Phase?
Sep 29, 2008 12:34 PM
- Sequenom Flying off Positive Investors Business Daily Mention
Aug 25, 2008 12:37 PM
- Analyst Comments: General Growth, Foster Wheeler, Myriad Genetics, Perfect World, Arris Group, Dresser-Rand, Almost Family, Animal Health, UniFirst
Aug 21, 2008 09:37 AM
- Periodicals Wrap-Up for Wednesday, August 20
Aug 20, 2008 10:15 AM
- Myriad Genetics, Inc. Reports Results for First Quarter of Fiscal 2009
Nov 04, 2008 06:30 AM
- Myriad Genetics Announces First Quarter Fiscal 2009 Financial Results Conference Call
Oct 23, 2008 11:53 AM
- Myriad Genetics Announces Plan to Separate Into Two Independent Public Companies
Oct 20, 2008 05:45 PM
- Myriad Genetics Acquires Novel Therapeutic Drug Management Technology From Saladax Biomedical
Oct 07, 2008 06:30 AM
- MultiVu Video Feed: WOMEN WITH A HEREDITARY RISK OF BREAST AND OVARIAN CANCER ARE ENCOURAGED TO GET TESTED - THOSE WITH AN ALTERED BRCA1 OR BRCA2 GENE HAVE A 56 TO 87 PERCENT RISK TO DEVELOP BREAST CANCER BY AGE 70
Sep 23, 2008 08:05 AM
- Myriad Genetics Announces Topline Results of Phase 1 Trial of Vivecon for HIV
Sep 17, 2008 06:30 AM
- Semi-annual Changes to the NASDAQ Q-50 Index
Sep 15, 2008 07:00 AM
- Myriad Genetics Board Explores Prospect of Separating Diagnostic and Pharmaceutical Businesses
Sep 11, 2008 06:30 AM
- Myriad Genetics Reports Financial Results for Fiscal 2008
Aug 19, 2008 06:30 AM
- Myriad Genetics Announces Fourth Quarter and Year-End Fiscal 2008 Financial Results Conference Call
Aug 12, 2008 06:07 PM
- Form 4 MYRIAD GENETICS INC For: Nov 21 Filed by: Laslie W Wayne (10K)
Nov 25, 2008 04:46 PM
- Form 4 WILSON LINDA S For: Nov 13 (10K)
Nov 17, 2008 05:51 PM
- Form 4 HENDERSON JOHN T For: Nov 13 (10K)
Nov 17, 2008 05:47 PM
- Form 4 MYRIAD GENETICS INC For: Nov 04 Filed by: Laslie W Wayne (10K)
Nov 06, 2008 04:46 PM
- Form 4 HOBDEN ADRIAN N For: Sep 29 (10K)
Sep 30, 2008 07:33 PM
- Form 4 MYRIAD GENETICS INC For: Sep 25 Filed by: Evans James S (10K)
Sep 29, 2008 07:44 PM
- Form 4 MYRIAD GENETICS INC For: Sep 23 Filed by: HOBDEN ADRIAN N (10K)
Sep 25, 2008 08:00 PM
- Form 4 MYRIAD GENETICS INC For: Sep 19 Filed by: HOBDEN ADRIAN N (10K)
Sep 23, 2008 07:11 PM
- Form 4 WILSON LINDA S For: Sep 19 (10K)
Sep 19, 2008 06:14 PM
- Form 4 HOBDEN ADRIAN N For: Sep 17 (10K)
Sep 19, 2008 06:08 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
MYGN
|
Compare to S&P
|
| YTD |
27.32 %
|
-0.01 %
|
| 4 Weeks |
-15.82 %
|
-0.26 %
|
| 12 Weeks |
-6.52 %
|
34.86 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -78.57 %
|
|
EPS Growth in Last Year: 266.67 %
|
|
Sales Growth in Last Quarter: -55.86 %
|
|
Sales Growth in Last Quarter: 52.59 %
|
|
|
